• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

熊果酸通过抑制 NOX4/NLRP3 炎性小体通路和细菌失调逆转肝纤维化。

Ursolic acid reverses liver fibrosis by inhibiting NOX4/NLRP3 inflammasome pathways and bacterial dysbiosis.

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.

出版信息

Gut Microbes. 2021 Jan-Dec;13(1):1972746. doi: 10.1080/19490976.2021.1972746.

DOI:10.1080/19490976.2021.1972746
PMID:34530693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8451456/
Abstract

Activation of the NOX4/NLRP3 inflammasome pathway has been associated with fibrosis in other organs. An imbalance in intestinal bacteria is an important driving factor of liver fibrosis through the liver-gut axis. This study aimed to explore whether the effect of ursolic acid (UA) on liver fibrosis was associated with the NOX4/NLRP3 inflammasome pathways and intestinal bacteria. Wild-type (WT), , and mice and AP-treated mice were injected with CCI4 and treated with or without UA. The intestinal contents of the mice were collected and analyzed by 16S rRNA sequencing. UA alleviated liver fibrosis, which manifested as decreases in collagen deposition, liver injury, and the expression of fibrosis-related factors, and the expression of NOX4 and NLRP3 was significantly inhibited by UA treatment. Even after CCI4 injection, liver damage and fibrosis-related factors were significantly decreased in , and AP-treated mice. Importantly, the expression of NLRP3 was obviously inhibited in and AP-treated mice. In addition, the diversity of intestinal bacteria and the abundance of probiotics in and mice was significantly higher than those in WT mice, while the abundance of harmful bacteria in and mice was significantly lower than that in WT mice. The NOX4/NLRP3 inflammasome pathway plays a crucial role in liver fibrosis and is closely associated with the beneficial effect of UA. The mechanism by which the NOX4/NLRP3 inflammasome pathway is involved in liver fibrosis may be associated with disordered intestinal bacteria.

摘要

NOX4/NLRP3 炎性小体通路的激活与其他器官的纤维化有关。肠道细菌失衡是通过肝肠轴导致肝纤维化的一个重要驱动因素。本研究旨在探讨熊果酸 (UA) 对肝纤维化的作用是否与 NOX4/NLRP3 炎性小体通路和肠道细菌有关。野生型 (WT)、 和 小鼠和 AP 处理的小鼠注射 CCI4 并分别用或不用 UA 处理。收集小鼠的肠道内容物并通过 16S rRNA 测序进行分析。UA 减轻了肝纤维化,表现为胶原沉积、肝损伤和纤维化相关因子的表达减少,UA 处理显著抑制了 NOX4 和 NLRP3 的表达。即使在 CCI4 注射后, 小鼠和 AP 处理的小鼠的肝损伤和纤维化相关因子明显减少。重要的是, 和 AP 处理的小鼠中 NLRP3 的表达明显受到抑制。此外, 和 小鼠的肠道细菌多样性和益生菌丰度明显高于 WT 小鼠,而 和 小鼠的有害细菌丰度明显低于 WT 小鼠。NOX4/NLRP3 炎性小体通路在肝纤维化中起关键作用,与 UA 的有益作用密切相关。NOX4/NLRP3 炎性小体通路参与肝纤维化的机制可能与肠道细菌紊乱有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8451456/28d6f826924c/KGMI_A_1972746_F0008_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8451456/1c20c5d5479f/KGMI_A_1972746_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8451456/b849b3944a1c/KGMI_A_1972746_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8451456/657889a4f1f4/KGMI_A_1972746_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8451456/4ba9be2f3727/KGMI_A_1972746_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8451456/2f928e2127ac/KGMI_A_1972746_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8451456/63caebc49208/KGMI_A_1972746_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8451456/5c1a8dee0a24/KGMI_A_1972746_F0007_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8451456/28d6f826924c/KGMI_A_1972746_F0008_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8451456/1c20c5d5479f/KGMI_A_1972746_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8451456/b849b3944a1c/KGMI_A_1972746_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8451456/657889a4f1f4/KGMI_A_1972746_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8451456/4ba9be2f3727/KGMI_A_1972746_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8451456/2f928e2127ac/KGMI_A_1972746_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8451456/63caebc49208/KGMI_A_1972746_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8451456/5c1a8dee0a24/KGMI_A_1972746_F0007_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/8451456/28d6f826924c/KGMI_A_1972746_F0008_OC.jpg

相似文献

1
Ursolic acid reverses liver fibrosis by inhibiting NOX4/NLRP3 inflammasome pathways and bacterial dysbiosis.熊果酸通过抑制 NOX4/NLRP3 炎性小体通路和细菌失调逆转肝纤维化。
Gut Microbes. 2021 Jan-Dec;13(1):1972746. doi: 10.1080/19490976.2021.1972746.
2
Ursolic acid reverses liver fibrosis by inhibiting interactive NOX4/ROS and RhoA/ROCK1 signalling pathways.熊果酸通过抑制交互性 NOX4/ROS 和 RhoA/ROCK1 信号通路逆转肝纤维化。
Aging (Albany NY). 2020 Jun 3;12(11):10614-10632. doi: 10.18632/aging.103282.
3
Gut Microbial Dysbiosis Is Associated With Profibrotic Factors in Liver Fibrosis Mice.肠道微生物失调与肝纤维化小鼠的促纤维化因子有关。
Front Cell Infect Microbiol. 2020 Jan 31;10:18. doi: 10.3389/fcimb.2020.00018. eCollection 2020.
4
Aucubin ameliorates liver fibrosis and hepatic stellate cells activation in diabetic mice via inhibiting ER stress-mediated IRE1α/TXNIP/NLRP3 inflammasome through NOX4/ROS pathway.毛蕊花糖苷通过抑制 ER 应激介导的 IRE1α/TXNIP/NLRP3 炎性小体通过 NOX4/ROS 途径改善糖尿病小鼠的肝纤维化和肝星状细胞活化。
Chem Biol Interact. 2022 Sep 25;365:110074. doi: 10.1016/j.cbi.2022.110074. Epub 2022 Aug 10.
5
Ginsenoside Rg1 ameliorates aging‑induced liver fibrosis by inhibiting the NOX4/NLRP3 inflammasome in SAMP8 mice.人参皂苷 Rg1 通过抑制 SAMP8 小鼠的 NOX4/NLRP3 炎性小体改善衰老诱导的肝纤维化。
Mol Med Rep. 2021 Nov;24(5). doi: 10.3892/mmr.2021.12441. Epub 2021 Sep 15.
6
Ursolic acid alleviates Kupffer cells pyroptosis in liver fibrosis by the NOX2/NLRP3 inflammasome signaling pathway.熊果酸通过NOX2/NLRP3炎性小体信号通路减轻肝纤维化中枯否细胞的焦亡。
Int Immunopharmacol. 2022 Dec;113(Pt A):109321. doi: 10.1016/j.intimp.2022.109321. Epub 2022 Oct 14.
7
Angiotensin-(1-7) Improves Liver Fibrosis by Regulating the NLRP3 Inflammasome via Redox Balance Modulation.血管紧张素 -(1 - 7)通过调节氧化还原平衡来调控NLRP3炎性小体从而改善肝纤维化。
Antioxid Redox Signal. 2016 May 10;24(14):795-812. doi: 10.1089/ars.2015.6498. Epub 2016 Mar 22.
8
Angiotensin(1-7) attenuated Angiotensin II-induced hepatocyte EMT by inhibiting NOX-derived H2O2-activated NLRP3 inflammasome/IL-1β/Smad circuit.血管紧张素(1-7)通过抑制NADPH氧化酶衍生的H2O2激活的NLRP3炎性小体/IL-1β/ Smad信号通路,减轻血管紧张素II诱导的肝细胞上皮-间质转化。
Free Radic Biol Med. 2016 Aug;97:531-543. doi: 10.1016/j.freeradbiomed.2016.07.014. Epub 2016 Jul 18.
9
NOX4 promotes Kupffer cell inflammatory response via ROS-NLRP3 to aggravate liver inflammatory injury in acute liver injury.NOX4 通过 ROS-NLRP3 促进枯否细胞炎症反应,加重急性肝损伤中的肝炎症损伤。
Aging (Albany NY). 2022 Jul 13;14(17):6905-6916. doi: 10.18632/aging.204173.
10
Angiotensin (1-7) inhibits arecoline-induced migration and collagen synthesis in human oral myofibroblasts via inhibiting NLRP3 inflammasome activation.血管紧张素 (1-7) 通过抑制 NLRP3 炎性小体激活抑制槟榔碱诱导的人口腔成纤维肌细胞迁移和胶原合成。
J Cell Physiol. 2019 Apr;234(4):4668-4680. doi: 10.1002/jcp.27267. Epub 2018 Sep 24.

引用本文的文献

1
TMT-based proteomics analysis identifies RPLP1 as a key protein target in ursolic acid Inhibition of colorectal cancer.基于TMT的蛋白质组学分析确定核糖体蛋白L35A1是熊果酸抑制结直肠癌的关键蛋白靶点。
Discov Oncol. 2025 Sep 1;16(1):1665. doi: 10.1007/s12672-025-03486-z.
2
Role of NLRP3 in the metabolism of bile acids and gut microbiota in CCl4-induced liver fibrosis.NLRP3在四氯化碳诱导的肝纤维化中胆汁酸代谢和肠道微生物群中的作用。
Microbiol Spectr. 2025 Jul 21:e0014825. doi: 10.1128/spectrum.00148-25.
3
Pharmacological and therapeutic effects of natural products on liver regeneration-a comprehensive research.

本文引用的文献

1
Exposure to hyperandrogen drives ovarian dysfunction and fibrosis by activating the NLRP3 inflammasome in mice.暴露于高雄性激素会通过激活 NLRP3 炎性小体在小鼠中导致卵巢功能障碍和纤维化。
Sci Total Environ. 2020 Nov 25;745:141049. doi: 10.1016/j.scitotenv.2020.141049. Epub 2020 Jul 22.
2
RIPK3 blockade attenuates tubulointerstitial fibrosis in a mouse model of diabetic nephropathy.RIPK3 阻断可减轻糖尿病肾病小鼠模型的肾小管间质纤维化。
Sci Rep. 2020 Jun 26;10(1):10458. doi: 10.1038/s41598-020-67054-x.
3
Inhibition of P2X7 Purinergic Receptor Ameliorates Cardiac Fibrosis by Suppressing NLRP3/IL-1 Pathway.
天然产物对肝脏再生的药理及治疗作用——一项综合研究
Chin Med. 2025 May 6;20(1):57. doi: 10.1186/s13020-025-01108-y.
4
Ursolic Acid Modulates Estrogen Conversion to Relieve Inflammation in Metabolic Dysfunction-associated Steatotic Liver Disease via HSD17B14.熊果酸通过HSD17B14调节雌激素转化以减轻代谢功能障碍相关脂肪性肝病中的炎症。
J Clin Transl Hepatol. 2025 Apr 28;13(4):269-277. doi: 10.14218/JCTH.2024.00414. Epub 2025 Mar 10.
5
Increased neprilysin expression is linked to atrial fibrotic remodeling in cardiovascular surgery patients.中性内肽酶表达增加与心血管手术患者的心房纤维化重塑有关。
Int J Cardiol Heart Vasc. 2025 Mar 17;57:101647. doi: 10.1016/j.ijcha.2025.101647. eCollection 2025 Apr.
6
Optimization of triterpenoids biosynthesis in Athelia termitophila as a source of natural products.优化嗜白蚁 Athelia termitophila 中三萜类化合物的生物合成以作为天然产物来源。
AMB Express. 2025 Apr 5;15(1):61. doi: 10.1186/s13568-025-01840-6.
7
NLRP3 inflammasome in cardiovascular diseases: an update.心血管疾病中的NLRP3炎性小体:最新进展
Front Immunol. 2025 Feb 26;16:1550226. doi: 10.3389/fimmu.2025.1550226. eCollection 2025.
8
Numerous liver abscesses after transjugular intrahepatic portosystemic shunt for decompensated liver cirrhosis: A case report.经颈静脉肝内门体分流术治疗失代偿期肝硬化后出现大量肝脓肿:一例报告
World J Radiol. 2025 Feb 28;17(2):101932. doi: 10.4329/wjr.v17.i2.101932.
9
Drug Advances in NAFLD: Individual and Combination Treatment Strategies of Natural Products and Small-Synthetic-Molecule Drugs.非酒精性脂肪性肝病的药物进展:天然产物与小分子合成药物的个体化及联合治疗策略
Biomolecules. 2025 Jan 17;15(1):140. doi: 10.3390/biom15010140.
10
Bacteria in hypertrophic scars promote scar formation through HSBP1-mediated autophagy.肥厚性瘢痕中的细菌通过HSBP1介导的自噬促进瘢痕形成。
Wound Repair Regen. 2025 Jan-Feb;33(1):e13253. doi: 10.1111/wrr.13253.
P2X7 嘌呤能受体抑制通过抑制 NLRP3/IL-1 通路减轻心脏纤维化。
Oxid Med Cell Longev. 2020 May 21;2020:7956274. doi: 10.1155/2020/7956274. eCollection 2020.
4
Alamandine attenuates hepatic fibrosis by regulating autophagy induced by NOX4-dependent ROS.阿拉曼丁通过调节 NOX4 依赖性 ROS 诱导的自噬来减轻肝纤维化。
Clin Sci (Lond). 2020 Apr 17;134(7):853-869. doi: 10.1042/CS20191235.
5
Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1/miR-141-mediated NLRP3 inflammasome and TGF-β1/Smads signaling in diabetic cardiomyopathy.褪黑素通过抑制 lncRNA MALAT1/miR-141 介导的 NLRP3 炎性小体和 TGF-β1/Smads 信号通路减轻糖尿病心肌病中的心肌纤维化。
FASEB J. 2020 Apr;34(4):5282-5298. doi: 10.1096/fj.201902692R. Epub 2020 Feb 17.
6
Protective effects of acarbose against vascular endothelial dysfunction through inhibiting Nox4/NLRP3 inflammasome pathway in diabetic rats.阿卡波糖通过抑制糖尿病大鼠 Nox4/NLRP3 炎性小体通路对血管内皮功能障碍的保护作用。
Free Radic Biol Med. 2019 Dec;145:175-186. doi: 10.1016/j.freeradbiomed.2019.09.015. Epub 2019 Sep 18.
7
Protective Effect of Ursolic Acid on the Intestinal Mucosal Barrier in a Rat Model of Liver Fibrosis.熊果酸对肝纤维化大鼠模型肠道黏膜屏障的保护作用
Front Physiol. 2019 Jul 30;10:956. doi: 10.3389/fphys.2019.00956. eCollection 2019.
8
Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4/NOX4/NF-κB pathway.右美托咪定通过调节TLR4/NOX4/NF-κB通路抑制NLRP3炎性小体激活,从而减轻脂多糖诱导的急性肾损伤。
J Cell Biochem. 2019 Oct;120(10):18509-18523. doi: 10.1002/jcb.29173. Epub 2019 Jun 26.
9
Structure and mechanisms of ROS generation by NADPH oxidases.活性氧簇的 NADPH 氧化酶生成的结构和机制。
Curr Opin Struct Biol. 2019 Dec;59:91-97. doi: 10.1016/j.sbi.2019.03.001. Epub 2019 Apr 30.
10
Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity.白细胞介素-1 及其相关细胞因子在炎症和免疫调节中的作用。
Immunity. 2019 Apr 16;50(4):778-795. doi: 10.1016/j.immuni.2019.03.012.